Muutke küpsiste eelistusi

Nanoneuroscience and Nanoneuropharmacology, Volume 180 [Kõva köide]

Edited by
  • Formaat: Hardback, 264 pages, kõrgus x laius: 262x192 mm, kaal: 800 g
  • Sari: Progress in Brain Research
  • Ilmumisaeg: 21-Dec-2009
  • Kirjastus: Elsevier Science Ltd
  • ISBN-10: 0444534318
  • ISBN-13: 9780444534316
Teised raamatud teemal:
  • Formaat: Hardback, 264 pages, kõrgus x laius: 262x192 mm, kaal: 800 g
  • Sari: Progress in Brain Research
  • Ilmumisaeg: 21-Dec-2009
  • Kirjastus: Elsevier Science Ltd
  • ISBN-10: 0444534318
  • ISBN-13: 9780444534316
Teised raamatud teemal:

This volume presents articles from the leading experts in the field in nanobiotechnology providing students and researcher a comprehensive review of the newly emerging area of neuroscience.

All aspects of nanomaterials induced alteration in brain function are considered.  Basic chapters on methods and ways to enhance nano-drug delivery into the brain are presented as well as chapters on functional and structural changes in the CNS, including gene expression and related issues.  Particular attention is given to possible therapeutic advancement regarding nano-drug formulation and their role in neuroprotection.



This volume presents articles from the leading experts in the field in nanobiotechnology, providing students and researchers with a comprehensive review of the newly emerging area of neuroscience.

All aspects of nanomaterials induced alteration in brain function are considered. Basic chapters on methods and ways to enhance nano-drug delivery into the brain are presented as well as chapters on functional and structural changes in the CNS, including gene expression and related issues. Particular attention is given to possible therapeutic advancement regarding nano-drug formulation and their role in neuroprotection.

List of Contributors
v
Preface vii
Acknowledgments xi
Section I. Nanodrug delivery and Imaging Techniques
Drug delivery to the brain using colloidal carriers
3(16)
Jiang Chang
Youssef Jallouli
Alexandre Barras
Nicole Dupont
Didier Betbeder
Quantum dot nanotechnologies for neuroimaging
19(16)
Gabriel A. Silva
Colloidal systems for CNS drug delivery
35(38)
Luca Costantino
Giovanni Tosi
Barbara Ruozi
Lucia Bondioli
Maria Angela Vandelli
Flavio Forni
Section II. Application of Nanotechnology in Brain Disease
Applications of nanotechnology in molecular imaging of the brain
73(24)
Martina A. McAteer
Robin P. Choudhury
Development of iron chelator-nanoparticle conjugates as potential therapeutic agents for Alzheimer disease
97(14)
Gang Liu
Ping Men
George Perry
Mark A. Smith
Section III. Nanoparticles Therapy and Neuroregeneration
Carbon nanotubes as substrates/scaffolds for neural cell growth
111(16)
William Lee
Vladimir Parpura
Neuromodulation: deep brain stimulation, sensory neuroprostheses, and the neural-electrical interface
127(14)
Russell J. Andrews
Nanoparticles: transport across the olfactory epithelium and application to the assessment of brain function in health and disease
141(14)
Michael Aschner
Section IV. Nanoneurotoxicity and Nanoneuroprotection
Nanoparticles influence pathophysiology of spinal cord injury and repair
155(26)
Hari Shanker Sharma
Dafin F. Muresanu
Aruna Sharma
Ranjana Patnaik
Jose Vicente Lafuente
Solid lipid nanoparticles and microemulsions for drug delivery: the CNS
181(12)
Maria Rosa Gasco
Lorenzo Priano
Gian Paolo Zara
Solid lipid nanoparticles for brain tumors therapy: state of the art and novel challenges
193(32)
Andrea M. Brioschi
Sara Calderoni
Gian Paolo Zara
Lorenzo Priano
Maria Rosa Gasco
Alessandro Mauro
Brain as an HIV sequestered site: use of nanoparticles as a therapeutic option
225(10)
Christopher J. Destache
Subject Index 235